81_FR_6030 81 FR 6007 - Subcommittee on Procedures Review (SPR), Advisory Board on Radiation and Worker Health, National Institute for Occupational Safety and Health Meeting

81 FR 6007 - Subcommittee on Procedures Review (SPR), Advisory Board on Radiation and Worker Health, National Institute for Occupational Safety and Health Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 81, Issue 23 (February 4, 2016)

Page Range6007-6008
FR Document2016-02081

Federal Register, Volume 81 Issue 23 (Thursday, February 4, 2016) 
[Federal Register Volume 81, Number 23 (Thursday, February 4, 2016)]
[Notices]
[Pages 6007-6008]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-02081]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Subcommittee on Procedures Review (SPR), Advisory Board on 
Radiation and Worker Health, National Institute for Occupational Safety 
and Health Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC), announces the following meeting for the 
aforementioned subcommittee:

DATES: 11:00 a.m.-4:30 p.m., EST, February 24, 2016.

ADDRESSES: Audio Conference Call via FTS Conferencing.
    Status: Open to the public, but without a public comment period. 
The public is welcome to submit written comments in advance of the 
meeting, to the contact person below. Written comments received in 
advance of the meeting will be included in the official record of the 
meeting. The public is also welcome to listen to the meeting by joining 
the teleconference at the USA

[[Page 6008]]

toll-free, dial-in number at 1-866-659-0537 and the pass code is 
9933701.
    Background: The Advisory Board on Radiation and Worker Health 
(ABRWH or the Advisory Board) was established under the Energy 
Employees Occupational Illness Compensation Program Act of 2000 to 
advise the President on a variety of policy and technical functions 
required to implement and effectively manage the new compensation 
program. Key functions of the Advisory Board include providing advice 
on the development of probability of causation guidelines that have 
been promulgated by the Department of Health and Human Services (HHS) 
as a final rule; advice on methods of dose reconstruction, which have 
also been promulgated by HHS as a final rule; advice on the scientific 
validity and quality of dose estimation and reconstruction efforts 
being performed for purposes of the compensation program; and advice on 
petitions to add classes of workers to the Special Exposure Cohort.
    In December 2000, the President delegated responsibility for 
funding, staffing, and operating the Advisory Board to HHS, which 
subsequently delegated this authority to CDC. National Institute for 
Occupational Safety and Health (NIOSH) implements this responsibility 
for CDC. The charter was issued on August 3, 2001, renewed at 
appropriate intervals, and will expire on August 3, 2017.
    Purpose: The Advisory Board is charged with (a) providing advice to 
the Secretary, HHS, on the development of guidelines under Executive 
Order 13179; (b) providing advice to the Secretary, HHS, on the 
scientific validity and quality of dose reconstruction efforts 
performed for this program; and (c) upon request by the Secretary, HHS, 
advise the Secretary on whether there is a class of employees at any 
Department of Energy facility who were exposed to radiation but for 
whom it is not feasible to estimate their radiation dose, and on 
whether there is reasonable likelihood that such radiation doses may 
have endangered the health of members of this class. SPR was 
established to aid the Advisory Board in carrying out its duty to 
advise the Secretary, HHS, on dose reconstruction. SPR is responsible 
for overseeing, tracking, and participating in the reviews of all 
procedures used in the dose reconstruction process by the NIOSH 
Division of Compensation Analysis and Support (DCAS) and its dose 
reconstruction contractor (Oak Ridge Associated Universities--ORAU).
    Matters for Discussion: The agenda for the Subcommittee meeting 
includes discussion of procedures in the following ORAU and DCAS 
technical documents: OCAS Technical Information Bulletin (TIB) 0014 
(``Rocky Flats Internal Dosimetry Coworker Extension''), ORAU OTIB 0013 
(``Individual Dose Adjustment Procedures for Y-12 Dose 
Reconstructions''), ORAU OTIB 0029 (``Internal Dose Reconstructions for 
Y-12''), ORAU OTIB 0039 (``Internal Dose Reconstructions for 
Hanford''), ORAU OTIB 0050 (``The Use of Rocky Flats Neutron Dose 
Reconstruction Project Data in Dose Reconstructions''), ORAU OTIB 0060 
(``Internal Dose Reconstructions''), Program Evaluation Report (PER) 
003 (``The Effects of Adding Ingestion Intakes to Bethlehem Steel 
Cases''), PER 004 (``Application of Photofluorography at the Pinellas 
Plant''), PER 005 (``Misinterpreted Application of External Dose Factor 
for Hanford Dose Reconstructions''), PER 029 (``Hanford TBD 
Revision''), PER 042 (``Linde Ceramic Plant TBD Revision''), PER 045 
(``Aliquippa Forge TBD Revision''), ORAU PROC 0042 (``Incomplete 
Monitoring at Y-12''), ORAU RPRT 0044 (``Analysis of Bioassay Data with 
Significant Fraction of Less-Than Results''); and a continuation of the 
comment-resolution process for other dose reconstruction procedures 
under review by the Subcommittee.
    The agenda is subject to change as priorities dictate.

FOR FURTHER INFORMATION CONTACT: Theodore Katz, Designated Federal 
Officer, NIOSH, CDC, 1600 Clifton Road NE., Mailstop E-20, Atlanta, 
Georgia 30333, Telephone (513) 533-6800, Toll Free 1(800) CDC-INFO, 
Email [email protected].
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2016-02081 Filed 2-3-16; 8:45 am]
 BILLING CODE 4163-19-P

Federal Register / Vol. 81, No. 23 / Thursday, February 4, 2016 / Notices 6007 DATES: 8:00 a.m.–6:00 p.m., EST, hexavalent vaccine (diphtheria and Matters for Discussion: The meeting February 24, 2016 tetanus toxoids and acellular pertussis will include the initial review, ADDRESSES: CDC, Tom Harkin Global adsorbed (DTaP)—inactivated polio discussion, and evaluation of Communications Center, 1600 Clifton vaccine (IVP)—Haemophilus influenzae applications received in response to Road NE., Building 19, Kent ‘‘Oz’’ type b (Hib)—hepatitis B (HepB). ‘‘Occupational Safety and Health Nelson Auditorium, Atlanta, Georgia Agenda items are subject to change as Education and Research Centers (ERC),’’ 30329. priorities dictate. PAR 15–303. Status: Open to the public, limited FOR FURTHER INFORMATION CONTACT: FOR FURTHER INFORMATION CONTACT: only by the space available. Time will Stephanie Thomas, National Center for George Bockosh, M.S., Scientific Review be available for public comment. The Immunization and Respiratory Diseases, Officer, CDC, NIOSH, 2400 Century public is welcome to submit written CDC, 1600 Clifton Road NE., MS–A27, Center Parkway NE., 4th Floor, Mailstop comments in advance of the meeting. Atlanta, Georgia 30329, telephone 404– E–74, Atlanta, Georgia 30345, Comments should be submitted in 639–8836; Email ACIP@CDC.GOV. Telephone: (412) 386–6465, GGB0@ writing by email to the contact person The Director, Management Analysis CDC.GOV and Donald Blackman, Ph.D., listed below by February 15, 2016. All and Services Office, has been delegated Scientific Review Officer, CDC, NIOSH, requests must contain the name, the authority to sign Federal Register 2400 Century Center Parkway NE., 4th address, and organizational affiliation of notices pertaining to announcements of Floor, Room 4204, Mailstop E–74, the speaker, as well as the topic being meetings and other committee Atlanta, Georgia 30345, Telephone: addressed. Written comments should management activities for both the (404) 498–6185, DYB7@CDC.GOV. not exceed one single-spaced typed page Centers for Disease Control and The Director, Management Analysis in length and delivered in 3 minutes or Prevention and the Agency for Toxic and Services Office, has been delegated less. Please note that the public Substances and Disease Registry. the authority to sign Federal Register comment period may end before the notices pertaining to announcements of Elaine L. Baker, time indicated, following the last call meetings and other committee Director, Management Analysis and Services for comments. Members of the public management activities, for both the Office, Centers for Disease Control and who wish to provide public comments Prevention. Centers for Disease Control and should plan to attend the public Prevention and the Agency for Toxic [FR Doc. 2016–02080 Filed 2–3–16; 8:45 am] comment session at the start time listed. Substances and Disease Registry. BILLING CODE 4163–18–P Written comments received in advance Elaine L. Baker, of the meeting will be included in the Director, Management Analysis and Services official record of the meeting. DEPARTMENT OF HEALTH AND Office, Centers for Disease Control and The meeting will be webcast live via HUMAN SERVICES Prevention. the World Wide Web; for instructions [FR Doc. 2016–02079 Filed 2–3–16; 8:45 am] and more information on ACIP please Centers for Disease Control and BILLING CODE 4163–18–P visit the ACIP Web site: http:// Prevention www.cdc.gov/vaccines/acip/index.html. Purpose: The committee is charged Disease, Disability, and Injury DEPARTMENT OF HEALTH AND with advising the Director, CDC, on the Prevention and Control Special HUMAN SERVICES appropriate use of immunizing agents. Emphasis Panel: Initial Review In addition, under 42 U.S.C. 1396s, the Centers for Disease Control and committee is mandated to establish and In accordance with Section 10(a)(2) of the Federal Advisory Committee Act Prevention periodically review and, as appropriate, revise the list of vaccines for (Pub. L. 92–463), the Centers for Disease Subcommittee on Procedures Review administration to vaccine-eligible Control and Prevention (CDC) (SPR), Advisory Board on Radiation children through the Vaccines for announces a meeting for the initial and Worker Health, National Institute Children (VFC) program, along with review of applications in response to for Occupational Safety and Health schedules regarding the appropriate Funding Opportunity Announcement Meeting periodicity, dosage, and (FOA) PAR 15–303, Occupational Safety contraindications applicable to the and Health Education and Research In accordance with section 10(a)(2) of vaccines. Further, under provisions of Centers (ERC). the Federal Advisory Committee Act the Affordable Care Act, at section 2713 DATES: 6:00 p.m.–8:00 p.m., February (Pub. L. 92–463), the Centers for Disease of the Public Health Service Act, 22, 2016 (Closed) Control and Prevention (CDC), immunization recommendations of the 7:00 a.m.–6:00 p.m., February 23, announces the following meeting for the ACIP that have been adopted by the 2016 (Closed) aforementioned subcommittee: Director of the Centers for Disease 7:00 a.m.–6:00 p.m., February 24, DATES: 11:00 a.m.–4:30 p.m., EST, Control and Prevention and appear on 2016 (Closed) February 24, 2016. the CDC immunization schedules must ADDRESSES: Hilton Alexandria Old ADDRESSES: Audio Conference Call via be covered by applicable health plans. Town, 1767 King Street, Alexandria, FTS Conferencing. Matters for Discussion: The agenda Virginia 22314, Telephone: (703) 837– Status: Open to the public, but will include discussions on: 0440. without a public comment period. The asabaliauskas on DSK5VPTVN1PROD with NOTICES Meningococcal vaccines; human Status: The meeting will be closed to public is welcome to submit written papillomavirus vaccines; influenza; the public in accordance with comments in advance of the meeting, to hexavalent vaccine (DTaP–IPV-Hib- provisions set forth in Section the contact person below. Written HepB); cholera vaccine; Japanese 552b(c)(4) and (6), Title 5 U.S.C., and comments received in advance of the encephalitis vaccine; and vaccine the Determination of the Director, meeting will be included in the official supply. A recommendation vote is Management Analysis and Services record of the meeting. The public is also scheduled for influenza. A Vaccines for Office, CDC, pursuant to Public Law 92– welcome to listen to the meeting by Children (VFC) vote is scheduled for 463. joining the teleconference at the USA VerDate Sep<11>2014 17:21 Feb 03, 2016 Jkt 238001 PO 00000 Frm 00027 Fmt 4703 Sfmt 4703 E:\FR\FM\04FEN1.SGM 04FEN1

6008 Federal Register / Vol. 81, No. 23 / Thursday, February 4, 2016 / Notices toll-free, dial-in number at 1–866–659– discussion of procedures in the DEPARTMENT OF HEALTH AND 0537 and the pass code is 9933701. following ORAU and DCAS technical HUMAN SERVICES Background: The Advisory Board on documents: OCAS Technical Radiation and Worker Health (ABRWH Information Bulletin (TIB) 0014 (‘‘Rocky Centers for Disease Control and or the Advisory Board) was established Flats Internal Dosimetry Coworker Prevention under the Energy Employees Extension’’), ORAU OTIB 0013 Occupational Illness Compensation Request for Nominations of (‘‘Individual Dose Adjustment Program Act of 2000 to advise the Candidates To Serve on the Procedures for Y–12 Dose Interagency Committee on Smoking President on a variety of policy and Reconstructions’’), ORAU OTIB 0029 and Health, Centers for Disease technical functions required to (‘‘Internal Dose Reconstructions for Y– Control and Prevention (CDC), implement and effectively manage the new compensation program. Key 12’’), ORAU OTIB 0039 (‘‘Internal Dose Department of Health and Human functions of the Advisory Board include Reconstructions for Hanford’’), ORAU Services (HHS) providing advice on the development of OTIB 0050 (‘‘The Use of Rocky Flats Neutron Dose Reconstruction Project The CDC is soliciting nominations for probability of causation guidelines that Data in Dose Reconstructions’’), ORAU possible membership on the Interagency have been promulgated by the OTIB 0060 (‘‘Internal Dose Committee on Smoking and Health Department of Health and Human Reconstructions’’), Program Evaluation (ICSH), Office on Smoking and Health Services (HHS) as a final rule; advice on Report (PER) 003 (‘‘The Effects of (OSH). methods of dose reconstruction, which The ICSH consists of five members have also been promulgated by HHS as Adding Ingestion Intakes to Bethlehem appointed by the Secretary from a final rule; advice on the scientific Steel Cases’’), PER 004 (‘‘Application of physicians and scientists who represent validity and quality of dose estimation Photofluorography at the Pinellas private entities involved in informing and reconstruction efforts being Plant’’), PER 005 (‘‘Misinterpreted performed for purposes of the the public about the health effects of Application of External Dose Factor for smoking. The members are selected by compensation program; and advice on Hanford Dose Reconstructions’’), PER petitions to add classes of workers to the the Secretary, HHS. The committee 029 (‘‘Hanford TBD Revision’’), PER 042 provides advice and guidance to the Special Exposure Cohort. (‘‘Linde Ceramic Plant TBD Revision’’), In December 2000, the President Secretary, HHS, and the Director, CDC PER 045 (‘‘Aliquippa Forge TBD regarding (a) coordination of all research delegated responsibility for funding, Revision’’), ORAU PROC 0042 and education programs and other staffing, and operating the Advisory Board to HHS, which subsequently (‘‘Incomplete Monitoring at Y–12’’), activities within the Department and delegated this authority to CDC. ORAU RPRT 0044 (‘‘Analysis of with other Federal, State, local and National Institute for Occupational Bioassay Data with Significant Fraction private agencies and (b) establishment Safety and Health (NIOSH) implements of Less-Than Results’’); and a and maintenance of liaison with this responsibility for CDC. The charter continuation of the comment-resolution appropriate private entities, Federal was issued on August 3, 2001, renewed process for other dose reconstruction agencies, and State and local public at appropriate intervals, and will expire procedures under review by the health agencies with respect to smoking on August 3, 2017. Subcommittee. and health activities. Purpose: The Advisory Board is Nominations are being sought for The agenda is subject to change as charged with (a) providing advice to the individuals who have expertise and priorities dictate. Secretary, HHS, on the development of qualifications necessary to contribute to guidelines under Executive Order FOR FURTHER INFORMATION CONTACT: the accomplishment of the committee’s 13179; (b) providing advice to the Theodore Katz, Designated Federal objectives. More information is available Secretary, HHS, on the scientific Officer, NIOSH, CDC, 1600 Clifton Road on the ICSH, OSH Web site: http:// validity and quality of dose NE., Mailstop E–20, Atlanta, Georgia www.cdc.gov/tobacco/ICSH/index.htm. reconstruction efforts performed for this 30333, Telephone (513) 533–6800, Toll Nominees will be selected based on program; and (c) upon request by the Free 1(800) CDC–INFO, Email ocas@ expertise in the field of tobacco control Secretary, HHS, advise the Secretary on cdc.gov. and multi-disciplinary expertise in whether there is a class of employees at public health. Additionally, desirable The Director, Management Analysis qualifications include: (1) Knowledge of any Department of Energy facility who were exposed to radiation but for whom and Services Office, has been delegated emerging tobacco control policies and it is not feasible to estimate their the authority to sign Federal Register experience in analyzing, evaluating, and radiation dose, and on whether there is notices pertaining to announcements of interpreting Federal, State and/or local reasonable likelihood that such meetings and other committee health or regulatory policy; or (2) radiation doses may have endangered management activities, for both the knowledge of emerging tobacco the health of members of this class. SPR Centers for Disease Control and products and the evolving environment was established to aid the Advisory Prevention and the Agency for Toxic of tobacco control and expertise in Board in carrying out its duty to advise Substances and Disease Registry. developing or contributing to the the Secretary, HHS, on dose development of policies and/or Elaine L. Baker, reconstruction. SPR is responsible for programs; or (3) familiarity of rapid and overseeing, tracking, and participating Director, Management Analysis and Services emerging surveillance systems that will asabaliauskas on DSK5VPTVN1PROD with NOTICES Office, Centers for Disease Control and allow for the timely evaluation of in the reviews of all procedures used in Prevention. the dose reconstruction process by the tobacco product regulation and/or the [FR Doc. 2016–02081 Filed 2–3–16; 8:45 am] impact of tobacco control interventions. NIOSH Division of Compensation Analysis and Support (DCAS) and its BILLING CODE 4163–19–P Federal employees will not be dose reconstruction contractor (Oak considered for membership. Ridge Associated Universities—ORAU). Members may be invited to serve for Matters for Discussion: The agenda for terms of up to four years. The U.S. the Subcommittee meeting includes Department of Health and Human VerDate Sep<11>2014 17:21 Feb 03, 2016 Jkt 238001 PO 00000 Frm 00028 Fmt 4703 Sfmt 4703 E:\FR\FM\04FEN1.SGM 04FEN1


Document Created: 2016-02-04 00:31:20
Document Modified: 2016-02-04 00:31:20
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
Dates11:00 a.m.-4:30 p.m., EST, February 24, 2016.
ContactTheodore Katz, Designated Federal Officer, NIOSH, CDC, 1600 Clifton Road NE., Mailstop E-20, Atlanta, Georgia 30333, Telephone (513) 533-6800, Toll Free 1(800) CDC-INFO, Email [email protected]
FR Citation81 FR 6007 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR